Art

J-GLOBAL ID：201902208255813900   Reference number：19S1365701

Myeloid cell-derived LRG attenuates adverse cardiac remodelling after myocardial infarction

Author (12)： Kumagai, Shohei (Laboratory of Clinical Science and Biomedicine, Graduate School of Pharmacological Sciences, Osaka University) ,  Nakayama, Hiroyuki (Laboratory of Clinical Science and Biomedicine, Graduate School of Pharmacological Sciences, Osaka University) ,  Obana, Masanori (Laboratory of Clinical Science and Biomedicine, Graduate School of Pharmacological Sciences, Osaka University) ,  Fujio, Yasushi (Laboratory of Clinical Science and Biomedicine, Graduate School of Pharmacological Sciences, Osaka University) ,  Fujimoto, Minoru (Laboratory of Immune Signals, National Institute of Biomedical Innovation) ,  Honda, Hiromi (Laboratory of Immune Signals, National Institute of Biomedical Innovation) ,  Serada, Satoshi (Laboratory of Immune Signals, National Institute of Biomedical Innovation) ,  Naka, Tetsuji (Laboratory of Immune Signals, National Institute of Biomedical Innovation) ,  Ishibashi-Ueda, Hatsue (Department of Pathology, National Cerebral and Cardiovascular Center) ,  Kasai, Atsushi (Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, Osaka University) ,  Sakata, Yasushi (Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine) ,  Sawa, Yoshiki (Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine)
Material： Cardiovascular Research
Volume： 109  Issue： 2  Page： 272-282  Publication year： 2016 
JST Material Number： SCOPUS  ISSN： 0008-6363  CODEN： CVREA 
Country of issue： United Kingdom (GBR)  Language： English (EN)

Terms in the title (1)： LRG